Objective: To characterize relationships between self-reported co-morbidity and functional outcomes in community-dwelling older adults, and to assess whether the impact of co-morbidity persists even after adjustment for baseline functional status.
Design: Prospective observational study. We examined associations between self-reported co-morbidity at baseline and functional outcomes at one year, with and without adjustment for baseline functional status.
Setting: Outpatient clinics at a managed care and a Veterans Affairs site.
Subjects: Four hundred and ”fty-seven community-dwelling older adults representing a broad spectrum of overall health status.
Main outcome measures: (a) New basic ADL (activities of daily living) problem during follow-up; (b) 10-point decline in the physical function index of the MOS-36 (MOS-PFI).
Results: Co-morbidity was associated with adverse functional outcomes in bivariable analyses. After adjustment for age and baseline functional status, an accumulated co-morbidity score provided additional explanatory power for predicting new ADL problems; odds ratios were 2.30 (1.09, 5.09) and 2.96 (1.48, 6.25) for 2 and 33 affected co-morbidity domains, respectively. The impact of baseline status was also important; odds ratios for new ADL problems were 4.77 (2.68, 8.81) when at least one instrumental activity of daily living (IADL) problem was present at baseline, and 15.6 (8.05, 31.3) when at least one basic ADL problem was present at baseline.
Conclusions: Accumulated self-reported co-morbidity has signi”cant negative effects on function at one year; these effects are attenuated but not eliminated by adjustment for baseline status. Co-morbidity adjustment is probably an important design element in clinical research focused on functional outcomes in older adults.
Get full access to this article
View all access options for this article.
References
1.
Guralnik JM. Assessing the impact of co-morbidity in the older population. Ann Epidemiol1996; 6: 376–380.
2.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis1987; 40: 373–383.
3.
Poses RM, McClish DK, Smith WR, Bekes C, Scott WE. Prediction of survival of critically ill patients by admission co-morbidity. J Clin Epidemiol1996; 49: 743–747.
4.
Shwartz M, Iezzoni LI, Moskowitz MA, Ash AS, Sawitz E. The importance of co-morbidities in explaining differences in patient costs. Med Care1996; 34: 767–782.
5.
Parmelee PA, Thuras PD, Katz IR, Lawton MP. Validation of the cumulative illness rating scale in a geriatric residential population. J Am Geriatr Soc1995; 43: 130–137.
6.
Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can co-morbidity be measured by questionnaire rather than medical record review?Med Care1996; 34: 73–84.
7.
Cornoni-Huntley JC, Foley DJ, Guralnik JM. Co-morbidity analysis: a strategy for understanding mortality, disability and use of health care facilities of older people. Int J Epidemiol1991; 20 (suppl 1): S8–S17.
8.
Furner SE, Rudberg MA, Cassel CK. Medical conditions differentially affect the development of IADL disability: implications for medical care and research. Gerontologist1995; 35: 444–450.
9.
Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of co-morbidity with disability in older women: the women’s health and aging study. J Clin Epidemiol1999; 52: 27–37.
10.
Fried LP, Guralnik JM. Disability in older adults: evidence regarding signi”cance, etiology, and risk. J Am Geriatr Soc1997; 45: 92–100.
11.
Folstein MF, Folstein ME, McHugh PR. ‘Mini-mental state:’ a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–198.
12.
Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med1995; 332: 556–561.
13.
Guralnik JM, Simonsick EM, Ferrucci L et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol1994; 49: M85–M94.
14.
Ware JF, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36): 1. Conceptual framework and item selection. Med Care1992; 30: 473–483.
15.
Fitti J, Kovar M. The supplement on aging to the 1984 national health interview survey: Vital and Health Statistics: Series 2, No. 21.
16.
Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale. J Psychiatr Res1982; 17: 37–49.
17.
Callahan CM, Wolinsky FD, Stump TE, Nienaber NA, Hui SL, Tierney WM. Mortality, symptoms, and functional impairment in late-life depression. J Gen Intern Med1998; 13: 746–752.
18.
Leibson CL, Garrard J, Nitz N et al. The role of depression in the association between self-rated physical health and clinically de”ned illness. Geronotologist1999; 39: 291–298.
19.
Inouye SK, Peduzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA1998; 279: 1187–1193.
20.
Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Co-morbidity and functional status are independent in older cancer patients. J Clin Oncol1998; 16: 1582–1587.
21.
Robinson JR, Young TK, Roos LL, Gelskey DE. Estimating the burden of disease: comparing administrative data and self-reports. Med Care1997; 35: 932–947.
22.
Paganini-Hill A, Chao A. Accuracy of recall of hip fracture, heart attack, and cancer: a comparison of postal survey data and medical records. Am J Epidemiol1993; 138: 101–106.
23.
Stadnyk K, Calder J, Rockwood K. Testing the measurement properties of the short form-36 health survey in a frail elderly population. J Clin Epidemiol1998; 51: 827–835.
